5 ms·

Rick from Comprehend here, we're also hiring. Definitely reach out if you're interested in transforming the medical industry! http://www.comprehend.com/careers

Rick from Comprehend here, we're also hiring. Definitely reach out if you're interested in transforming the medical industry! http://www.comprehend.com/careers http://www.comprehend.com/careers

nawitus 13y ago
Do you hire non-Americans? (Not that I'm looking at the moment, but I think this should be mentioned on startup job postings).
- rmorrison 13y ago
  Yes we do = )
count 13y ago
Silly question, but you don't mention security or HIPAA/HITECH anywhere on your site (or in jobs). Are you guys working on that, or is it just 'assumed' that your stack and cloud capability is compliant?
- judgardner 13y ago
  Subjects enrolled in clinical trials fall under informed consent and are outside HIPPA/HITECH. We actually take steps beyond either of those standards to ensure the data, costing pharma billions to create, is not breached.
emidln 13y ago
Don't most Life Sciences companies already do this internally? I mean, I only have anecdotal evidence, but I worked on and released a couple versions of something for Abbott Labs that sounds eerily similar to what the press release mentions you doing (actually, went a lot further into budget forecasting (including updating and alerting for deviations based on incoming data automatically) and automatic payment calculation and authorization in addition to collaboration, data input, time keeping, and dashboarding for analysts/executives. In any event, good luck to you. From what I've seen from the inside, newer tech stacks can deal some serious disruption in a very short time frame.
- rmorrison 13y ago
  Most companies do something internally, but it's typically slow, expensive, out-of-date, breaks frequently, and is prone to errors.
tjpd 13y ago
Congratulations Rick! Great news.
pinaceae 13y ago
Congrats, cool topic. Impressive stuff. We're tackling eTMF plus other R&D from a content perspective through SaaS. See you're integrating with Medidata as well. Greetings from Pleasanton ;)
- rmorrison 13y ago
  Veeva? You should stop by next time you're in Palo Alto, would love to meet. Email is in my profile.
dsl 13y ago
I invested in a clinical trials company many years ago (operating an investigative site), and I'm curious what kind of traction you've gotten from the big pharmaceutical companies? I totally get how it is a compelling story for investors, but I have serious doubts about adoption and use. It was my experience that data and sound record keeping was a secondary to approvals. Many times paperwork was "corrected" and patients were excluded because of serious adverse events. Unless your model is to help identify exclusionary criteria retroactively?
- rmorrison 13y ago
  The industry has been drastically changing over the past decade. 15 years ago, all data collection was paper based. Then came Electronic Data Collection systems. Now, there are cloud systems likes Medidata Rave and Veeva which are doing exceptionally well. This change has created tremendous opportunity for new startups. This is happening across all enterprise verticals, and this is why there is such an opportunity for enterprise startups. As Warren Hogarth says in the original article "There’s about a trillion dollars of enterprise software", much of which will "transition to [specialized] enterprise software... and create multi-billion dollar companies".
foobarqux 13y ago
Based on your linkedin profiles neither of you has a life sciences background. How did you guys come up with this idea?
- rmorrison 13y ago
  We both do. I've actually been involved in writing clinical analytics software since 2000, including having been one of the lead developers on software used by the FDA and top pharma. Jud previously had a consulting company in the space performing data integrations.
flarg 13y ago
Rick, one of the biggest costs I hear about in the field is the cost of pre-allocating funds to upcoming trials without knowing how much to pre-allocate. The other is knowing how to profile clinicians and help them to raise their ability to recruit patients. Do you manage to address either of these points?

Rick from Comprehend here, we're also hiring. Definitely reach out if you're interested in transforming the medical industry! http://www.comprehend.com/careers http://www.comprehend.com/careers

nawitus 13y ago

Do you hire non-Americans? (Not that I'm looking at the moment, but I think this should be mentioned on startup job postings).

rmorrison 13y ago
Yes we do = )

count 13y ago

Silly question, but you don't mention security or HIPAA/HITECH anywhere on your site (or in jobs). Are you guys working on that, or is it just 'assumed' that your stack and cloud capability is compliant?

judgardner 13y ago
Subjects enrolled in clinical trials fall under informed consent and are outside HIPPA/HITECH. We actually take steps beyond either of those standards to ensure the data, costing pharma billions to create, is not breached.

emidln 13y ago

Don't most Life Sciences companies already do this internally? I mean, I only have anecdotal evidence, but I worked on and released a couple versions of something for Abbott Labs that sounds eerily similar to what the press release mentions you doing (actually, went a lot further into budget forecasting (including updating and alerting for deviations based on incoming data automatically) and automatic payment calculation and authorization in addition to collaboration, data input, time keeping, and dashboarding for analysts/executives. In any event, good luck to you. From what I've seen from the inside, newer tech stacks can deal some serious disruption in a very short time frame.

rmorrison 13y ago
Most companies do something internally, but it's typically slow, expensive, out-of-date, breaks frequently, and is prone to errors.

tjpd 13y ago

Congratulations Rick! Great news.

pinaceae 13y ago

Congrats, cool topic. Impressive stuff. We're tackling eTMF plus other R&D from a content perspective through SaaS. See you're integrating with Medidata as well. Greetings from Pleasanton ;)

rmorrison 13y ago
Veeva? You should stop by next time you're in Palo Alto, would love to meet. Email is in my profile.

dsl 13y ago

I invested in a clinical trials company many years ago (operating an investigative site), and I'm curious what kind of traction you've gotten from the big pharmaceutical companies? I totally get how it is a compelling story for investors, but I have serious doubts about adoption and use. It was my experience that data and sound record keeping was a secondary to approvals. Many times paperwork was "corrected" and patients were excluded because of serious adverse events. Unless your model is to help identify exclusionary criteria retroactively?

rmorrison 13y ago
The industry has been drastically changing over the past decade. 15 years ago, all data collection was paper based. Then came Electronic Data Collection systems. Now, there are cloud systems likes Medidata Rave and Veeva which are doing exceptionally well. This change has created tremendous opportunity for new startups. This is happening across all enterprise verticals, and this is why there is such an opportunity for enterprise startups. As Warren Hogarth says in the original article "There’s about a trillion dollars of enterprise software", much of which will "transition to [specialized] enterprise software... and create multi-billion dollar companies".

foobarqux 13y ago

Based on your linkedin profiles neither of you has a life sciences background. How did you guys come up with this idea?

rmorrison 13y ago
We both do. I've actually been involved in writing clinical analytics software since 2000, including having been one of the lead developers on software used by the FDA and top pharma. Jud previously had a consulting company in the space performing data integrations.

flarg 13y ago

Rick, one of the biggest costs I hear about in the field is the cost of pre-allocating funds to upcoming trials without knowing how much to pre-allocate. The other is knowing how to profile clinicians and help them to raise their ability to recruit patients. Do you manage to address either of these points?